Guidelines for prescribing combined oral contraceptives

EDITOR,-The clinical and scientific committee of the Faculty of Family Planning and Reproductive Health Care has noted a wide range of expert views on the recent publications on the combined oral contraceptive and venous thromboembolism 1 2 3 4 5 6 and has circulated a position paper. 7 The new stud...

Full description

Saved in:
Bibliographic Details
Published in:BMJ 1996-01, Vol.312 (7023), p.121-122
Main Authors: Mills, A M, Wilkinson, C L, Bromham, D R, Elias, J, Fotherby, K, Guillebaud, J, Kubba, A, Wade, A
Format: Article
Language:English
Subjects:
Birth control
Committees
Contraception
Contraceptives, Oral, Combined - adverse effects
Contraceptives, Oral, Synthetic - adverse effects
Counseling
Desogestrel - adverse effects
Drug Prescriptions
Family planning
Financial risk
Health risk assessment
Humans
Letter
Letters
Myocardial infarction
Norpregnenes - adverse effects
Oral contraceptives
Practice Guidelines as Topic
Prescription drugs
Reproductive health
Risk
Studies
Thromboembolism
Thromboembolism - chemically induced
Varicose veins
Vascular diseases
Venous thrombosis
Women
Womens health
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:EDITOR,-The clinical and scientific committee of the Faculty of Family Planning and Reproductive Health Care has noted a wide range of expert views on the recent publications on the combined oral contraceptive and venous thromboembolism 1 2 3 4 5 6 and has circulated a position paper. 7 The new studies confirm that low dose combined oral contraceptives carry an extremely low risk for healthy women.
ISSN:0959-8138
1468-5833
1756-1833
DOI:10.1136/bmj.312.7023.121a